Nanomedicine delivery systems remodel the immunosuppressive microenvironment of colorectal cancer: synergistic strategies and mechanisms of targeted immune checkpoint inhibitors - Top-Institutions - MDSpire

Nanomedicine delivery systems remodel the immunosuppressive microenvironment of colorectal cancer: synergistic strategies and mechanisms of targeted immune checkpoint inhibitors

  • By

  • Pengcheng Zhu

  • Anna Han

  • Chunhua Quan

  • June 26, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Nanomedicine

  • #2

    The Ohio State University Comprehensive Cancer Center
    The Ohio State University Comprehensive Cancer Center

    Columbus, Ohio

    Key Differentiators

    • Oncology

  • #3

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Oncology

  • #4

    Washington University School of Medicine
    Washington University School of Medicine

    St. Louis, Missouri

    Key Differentiators

    • Oncology

  • #5

    University of Massachusetts Amherst
    University of Massachusetts Amherst

    Amherst, Massachusetts

    Key Differentiators

    • Biomedical Engineering

Original Source(s)

Nanomedicine delivery systems remodel the immunosuppressive microenvironment of colorectal cancer: synergistic strategies and mechanisms of targeted immune checkpoint inhibitors

  • by Pengcheng Zhu, Anna Han, Chunhua Quan

  • June 26, 2026

Related Content

The mechanism of action, clinical significance, and research progress of tumor antigen-specific T cells in the treatment of HCC

Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials

Integrative oncology in colorectal cancer: evidence-based strategies from prevention through survivorship